Alcolase Patents

Patent portfolio assigned to Alcolase (verified via public assignee records). Estimated patent count: 1. Copenhagen biotech developing enzyme/liposomal remedy for alcohol intolerance (ALDH2 deficiency); Ada Ventures/Antler-backed, raised EUR1.5M 2026. Patent WO2024199693A1 'Liposomes for enzymatic degradation of ingested ethanol' assigned to Alcolase ApS (inventors Mads Emil Mikkelsen, Jeppe Malthe Mikkelsen, Mikkel Holstener Precht). No named customers (pre-market).